Clinicopathological characteristics and prognostic outcomes of pregnancy-associated colorectal cancer: A 24-year experience

Figure 1 The relationship between tumor-node-metastasis stage and the time to diagnosis of pregnancy-associated colorectal cancer affects obstetric treatment modalities and fetal prognoses. TNM: Tumor-node-metastasis.

Figure 2 Treatment strategies. TNM: Tumor-node-metastasis.

Figure 3 Kaplan-Meier estimates of the overall survival of all pregnancy-associated colorectal cancer patients.

Figure 4 Kaplan-Meier estimates of the overall survival. A: Type of pathology; B: Grade of differentiation. SRCC: Signet-ring cell carcinoma.

Figure 5 Kaplan-Meier estimates of the overall survival of all pregnancy-associated colorectal cancer patients with different tumor-node-metastasis stages. A: T; B: N; C: M; D: Tumor-node-metastasis. TNM: Tumor-node-metastasis.

Figure 6 Kaplan-Meier survival estimates for pregnancy-associated colorectal cancer patients diagnosed during pregnancy vs those diagnosed postpartum. A: 2-year overall survival rates; B: 5-year survival rates.

Figure 7 Kaplan-Meier estimates of the overall survival of pregnancy-associated colorectal cancer patients. A: Tumor locations; B: < 35-years-old vs ≥ 35-years-old.

Figure 8 Statistical analysis of the initial symptoms of patients. A: Initial symptoms presented by patients diagnosed with different tumor-node-metastasis stages; B: Initial symptoms exhibited by the patients when the diagnosis was confirmed based on different tumor locations. TNM: Tumor-node-metastasis.